Eight innovative tools that are reimagining web applications and how we build them. Welcome to the Great Unbloating.

A family sold their townhouse in Bradford, Ont., about 70 kilometres north of downtown Toronto, and set themselves a ...

When Trai Hume signed for Sunderland for just £200,000 when they were in League One, he would not have in his wildest dreams thought he would be scoring to send the club into Europe.

Ajax will face Utrecht on Sunday in a bid to secure the final European ticket available to Eredivisie sides. Ajax, who are having to play their games in Volendam while their stadium is unavailable, ...

While the Ajax squad focuses on salvaging their current campaign, technical director Jordi Cruijff is working behind the scenes to secure a successor for interim boss Oscar Garcia. Michel of Girona ...

Arne Slot has turned down the chance to take charge of Ajax and wants to continue as the manager of Liverpool, according to a reliable Dutch journalist. Slot was appointed the Liverpool manager in the ...

Trials of the British Army’s Ajax armoured vehicles are set to resume, despite major delays amid concern for soldiers’ safety. Minister for Defence Readiness and Industry Luke Pollard announced in ...

Trials of the British Army's Ajax armoured vehicle will be "proceeding cautiously" after they were halted last year, a defence minister has said. A decision was made to stop using the Ajax after ...

Add Yahoo as a preferred source to see more of our stories on Google. Colonel Hamish de Bretton Gordon, late of the Royal Tank Regiment, prepares to test drive the Ajax for the Telegraph The most ...

Eli Lilly LLY-1.93%decrease; red down pointing triangle continued its recent buying spree, agreeing to pay up to $2.3 billion for Ajax Therapeutics in a deal that bolsters the drugmaker’s blood-cancer ...

Eli Lilly (LLY) has agreed to acquire biopharmaceutical company Ajax Therapeutics for up to $2.3B in cash, inclusive of an upfront payment and subsequent payments upon the achievement of certain ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...